Personal Capital Advisors’s Genocea Biosciences, Inc. GNCA Stock Holding History

Personal Capital Advisors’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15,000	Closed	-$19K	–	502
2022 Q1	$19K	Hold	15,000	–	–	﹤0.01%	488
2021 Q4	$17K	Hold	15,000	–	–	﹤0.01%	547
2021 Q3	$29K	Hold	15,000	–	–	﹤0.01%	493
2021 Q2	$35K	Hold	15,000	–	–	﹤0.01%	483
2021 Q1	$41K	Hold	15,000	–	–	﹤0.01%	472
2020 Q4	$36K	Buy	+15,000	New	+$34.2K	﹤0.01%	452

Other funds holding GNCA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Personal Capital Advisors's GNCA Position: Q2 2022 in Review

Personal Capital Advisors sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2022, closing a stake of 15,000 shares — an estimated $19K sold.

Personal Capital Advisors first reported a position in GNCA in Q4 2020 and held it in 6 quarters. The position peaked at $41K in Q1 2021. 5 funds tracked by Wall St. Rank hold GNCA as of Q2 2022.

Personal Capital Advisors reported no remaining Genocea Biosciences, Inc. position as of Q2 2022 after selling out during the quarter.
Personal Capital Advisors sold 15,000 Genocea Biosciences, Inc. shares in Q2 2022, an estimated $19K.
Personal Capital Advisors first reported a position in Genocea Biosciences, Inc. in Q4 2020 and held it in 6 quarters.
Personal Capital Advisors's Genocea Biosciences, Inc. position peaked at $41K in Q1 2021.
5 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2022.

Based on Personal Capital Advisors's 13F filing for Q2 2022, filed 4 Aug 2022.